Fucoidan ingredients supplier Marinova named Health & Wellness Ingredient Innovator of the Year by Global Health & Pharma Magazine
The Australian biotechnology company develops high-purity seaweed extracts for human health.
Marinova Pty Ltd. (Tasmania, Australia) won an award in Global Health & Pharma Magazine’s 2023 International Life Sciences Awards in the category of Health & Wellness Ingredient Innovator of the Year. The Australian biotechnology company develops high-purity seaweed extracts for human health, particularly fucoidan compounds, derived from select brown seaweed species and containing highly bioactive polysaccharides.
The company describes its Maritech fucoidan extracts, suited for nutritional supplements, functional foods/beverages, skincare products, and animal health products, as “the world’s only high-purity, certified-organic fucoidan extracts with global regulatory acceptance.”
In a press release, Marinova’s CEO Paul Garrott, stated, “The unrivaled quality and efficacy of Maritech organic fucoidans is based on two decades of rigorous scientific investigation and the development of an advanced proprietary extraction process.”
Prinova acquires Aplinova to further increase its footprint in Latin America
April 7th 2025Prinova has recently announced the acquisition of Brazilian ingredients distributor Aplinova, which is a provider of specialty ingredients for a range of market segments that include food, beverage, supplements, and personal care.
